These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23370422)

  • 1. The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs.
    Reyes C; DaCosta Byfield S; Linke R; Satram-Hoang S; Teitelbaum AH
    Melanoma Res; 2013 Apr; 23(2):159-66. PubMed ID: 23370422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care population.
    Vekeman F; Cloutier M; Yermakov S; Amonkar MM; Arondekar B; Duh MS
    Melanoma Res; 2014 Dec; 24(6):602-10. PubMed ID: 24926818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.
    Baser O; Wei W; Henk HJ; Teitelbaum A; Xie L
    Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States.
    Copher R; Cerulli A; Watkins A; Laura Monsalvo M
    J Med Econ; 2012; 15(5):947-55. PubMed ID: 22554140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of metastatic breast cancer: a U.S. managed care perspective.
    Montero AJ; Eapen S; Gorin B; Adler P
    Breast Cancer Res Treat; 2012 Jul; 134(2):815-22. PubMed ID: 22684273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma.
    Atkins M; Coutinho AD; Nunna S; Gupte-Singh K; Eaddy M
    J Med Econ; 2018 Feb; 21(2):212-217. PubMed ID: 29022427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
    Alexandrescu DT
    Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care.
    Ivanova JI; Birnbaum HG; Schiller M; Kantor E; Johnstone BM; Swindle RW
    Spine J; 2011 Jul; 11(7):622-32. PubMed ID: 21601533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare costs, treatment patterns, and resource utilization among pancreatic cancer patients in a managed care population.
    DaCosta Byfield S; Nash Smyth E; Mytelka D; Bowman L; Teitelbaum A
    J Med Econ; 2013 Dec; 16(12):1379-86. PubMed ID: 24074258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource use in advanced prostate cancer patients treated with docetaxel.
    Mehra M; Wu Y; Dhawan R
    J Med Econ; 2012; 15(5):836-43. PubMed ID: 22463616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
    Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare costs and nonadherence among chronic opioid users.
    Leider HL; Dhaliwal J; Davis EJ; Kulakodlu M; Buikema AR
    Am J Manag Care; 2011 Jan; 17(1):32-40. PubMed ID: 21348566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic and health care resource utilization burden of central nervous system metastases in patients with metastatic melanoma.
    Tawbi H; Bartley K; Seetasith A; Kent M; Lee J; Burton E; Haydu L; McKenna E
    J Manag Care Spec Pharm; 2022 Mar; 28(3):342-353. PubMed ID: 35199578
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative healthcare costs in patients with metastatic melanoma in the USA.
    Chang CL; Schabert VF; Munakata J; Donga P; Abhyankar S; Reyes CM; Yim YM
    Melanoma Res; 2015 Aug; 25(4):312-20. PubMed ID: 25882026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.